{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06080789",
            "orgStudyIdInfo": {
                "id": "RABI-767-201"
            },
            "organization": {
                "fullName": "Panafina, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis",
            "officialTitle": "A Phase 2a, Multi-Center, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 Administered by Endoscopic Ultrasound-Guided Peripancreatic Injection Plus Standard-of-Care Versus Standard-of-Care Only in Participants With Predicted Severe Acute Pancreatitis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-the-safety-and-efficacy-of-a-single-dose-of-rabi-in-participants-with-acute-pancreatitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-08",
            "studyFirstSubmitQcDate": "2023-10-08",
            "studyFirstPostDateStruct": {
                "date": "2023-10-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Panafina, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis.\n\nThe main question the study aims to answer is:\n\n\u2022 Is a single-dose of RABI-767 given by EUS-guided peripancreatic injection safe in patients with predicted severe acute pancreatitis.\n\nThe study also aims to answer:\n\n\u2022 Is a single-dose of RABI-767 given by EUS-guided peripancreatic injection effective in treating patients with predicted severe acute pancreatitis.\n\nStudy participants will be randomly assigned (like the flip of a coin) to receive a single dose of RABI-767 plus supportive care or supportive care only.\n\nThe study sponsor will compare safety and efficacy data collected from participants who receive RABI-767 to participants who receive supportive care only to test if RABI-767 is safe and effective."
        },
        "conditionsModule": {
            "conditions": [
                "Acute Pancreatitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "RABI-767 plus Standard-of-Care",
                    "type": "EXPERIMENTAL",
                    "description": "Single-dose 125 mg RABI-767 plus standard-of-care",
                    "interventionNames": [
                        "Drug: RABI-767"
                    ]
                },
                {
                    "label": "Standard-of-Care Only",
                    "type": "NO_INTERVENTION",
                    "description": "No Intervention, Standard-of-Care Only"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "RABI-767",
                    "description": "125 mg single-dose given by endoscopic-ultrasound (EUS) guided peripancreatic injection.",
                    "armGroupLabels": [
                        "RABI-767 plus Standard-of-Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants with Adverse Events",
                    "description": "An adverse event (AE) is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the study intervention, regardless of its causal relationship to the study intervention. For the purposes of this study, any AE occurring in any study participant (regardless of treatment group assignment) at any time after enrollment/randomization, even if no study intervention has been administered, will be recorded.",
                    "timeFrame": "Enrollment/Randomization to Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Number of Participants with Serious Adverse Events",
                    "description": "A serious adverse event (SAE) is an AE, regardless of causality, that fulfills one or more protocol defined criteria for being serious.",
                    "timeFrame": "Enrollment/Randomization to Day 35 Follow-up"
                },
                {
                    "measure": "Change from Baseline in Clinical Chemistry Parameters",
                    "timeFrame": "Baseline to Day 7"
                },
                {
                    "measure": "Change from Baseline in Hematology Parameters",
                    "timeFrame": "Baseline to Day 7"
                },
                {
                    "measure": "Change from Baseline in Vital Signs",
                    "timeFrame": "Baseline to Day 7"
                },
                {
                    "measure": "Change from Baseline in Pulse Oximetry and Oxygen Delivery Measurements",
                    "timeFrame": "Baseline to Day 7"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Development of Severe Acute Pancreatitis",
                    "description": "Defined as \\>48 hours persistent organ failure",
                    "timeFrame": "Day 1 to Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Development of New Onset Moderately Severe Acute Pancreatitis",
                    "description": "Defined as transient organ failure and/or local or systemic complications without persistent organ failure",
                    "timeFrame": "Day 1 to Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Development of Pancreatic Necrosis",
                    "description": "As identified on CECT/CEMRI imaging; may be further sub-grouped into \\<30%, 30%-50%, and \\>50% pancreatic necrosis, if data allow.",
                    "timeFrame": "Baseline to Day 60 Follow-up"
                },
                {
                    "measure": "Development of Local Complications of Acute Pancreatitis",
                    "description": "As identified on CECT/CEMRI imaging; may be further sub-grouped by type of complication, if data allow.",
                    "timeFrame": "Baseline to Day 60 Follow-up"
                },
                {
                    "measure": "Mortality due to acute pancreatitis and/or complications secondary to acute pancreatitis",
                    "description": "Death caused by acute pancreatitis and/or complications secondary to acute pancreatitis",
                    "timeFrame": "Day 1 to Day 60 Follow-up"
                },
                {
                    "measure": "Mortality due to any cause",
                    "description": "Death due to any cause",
                    "timeFrame": "Day 1 to Day 60 Follow-up"
                },
                {
                    "measure": "Days in Hospital",
                    "timeFrame": "Day 1 through Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Re-hospitalization for acute pancreatitis or related complications",
                    "description": "Number of participants re-hospitalized for acute pancreatitis or related complications out of total participants who are discharged.",
                    "timeFrame": "From initial hospital discharge to Day 35 Follow-up"
                },
                {
                    "measure": "Length of Stay in Intensive Care Unit",
                    "timeFrame": "Day 1 through Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Development of New Onset Infection",
                    "description": "May be further sub-grouped by: pancreatic, peripancreatic, and extra-pancreatic infections, as data allow.",
                    "timeFrame": "Day 1 to Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Change in Modified Marshall Score",
                    "timeFrame": "From Baseline through Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Change in Sequential Organ Failure Assessment (SOFA) Score",
                    "timeFrame": "From Baseline through Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Change in Systemic Inflammatory Response Syndrome (SIRS) Assessment",
                    "timeFrame": "From Baseline through Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Change in Abdominal Pain Numeric Rating Score",
                    "timeFrame": "From Baseline through Day 28 (or hospital discharge, if earlier)"
                },
                {
                    "measure": "Change in Computed Tomography Severity Index (CTSI) Score for Pancreatitis",
                    "timeFrame": "From Baseline through Day 60 Follow-up"
                },
                {
                    "measure": "Change in Modified Computed Tomography Severity Index (mCTSI) Score for Pancreatitis",
                    "timeFrame": "From Baseline through Day 60 Follow-up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Diagnosis of acute pancreatitis\n* Predicted severe acute pancreatitis, based on protocol defined criteria\n* Lack of clinically meaningful improvement from status at admission, at the discretion of Investigator, at the time of randomization\n* Suitable for EUS-guided study drug administration procedure\n* Contrast-enhanced computed tomography (CECT) or contrast-enhanced magnetic resonance imaging (CEMRI) of the abdomen/pancreas available for the evaluation of exclusion criteria\n\nKey Exclusion Criteria:\n\n* Confirmed severe acute pancreatitis as defined by the Revised Atlanta Classification of Acute Pancreatitis (ie, Persistent \\[\\> 48 hours\\] organ failure, per Modified Marshall Score), prior to randomization\n* Anticipated discharge from hospital within 48 hours of randomization\n* Pancreatic necrosis on screening CECT or CEMRI\n* History of previous pancreatic necrosis, including necrosectomy\n* History of calcific chronic pancreatitis\n* Evidence of cholangitis",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kelly Abernathy",
                    "role": "CONTACT",
                    "phone": "9194609500",
                    "email": "kabernathy@arrivobio.com"
                }
            ],
            "locations": [
                {
                    "facility": "Keck Hospital of USC and LA County Hospital",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Research Coordinator",
                            "role": "CONTACT"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "323-409-6939"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of Florida Health",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32608",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Research Coordinator",
                            "role": "CONTACT",
                            "phone": "352-273-9483"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Orlando Health",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Research Coordinator",
                            "role": "CONTACT",
                            "phone": "321-841-6649"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Indiana University Health University Hospital",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Research Coordinator",
                            "role": "CONTACT",
                            "phone": "317-962-3586"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Dartmouth Hitchcock Medical Center",
                    "status": "RECRUITING",
                    "city": "Lebanon",
                    "state": "New Hampshire",
                    "zip": "03756",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Research Coordinator",
                            "role": "CONTACT",
                            "phone": "603-653-3651"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.64229,
                        "lon": -72.25176
                    }
                },
                {
                    "facility": "NYU Langone Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "There is no plan to make individual participant data (IPD) available to other researchers."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010195",
                    "term": "Pancreatitis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13115",
                    "name": "Pancreatitis",
                    "asFound": "Pancreatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}